Shape of Barrett’s epithelium effects prevalence of erosive esophagitis

	Tweet

Barrett’s epithelium is recognized as a complication of erosive esophagitis and is the pre-malignant condition for adenocarcinoma of the esophagus.

A research team from Yokohama City University School of Medicine hypothesized that some macroscopic features of Barrett’s epithelium might be useful for identifying a subgroup with a high risk for the development of esophageal adenocarcinoma. Their study will be published on January 28, 2010 in the World Journal of Gastroenterology.

They enrolled 869 patients who underwent endoscopy during a health checkup at their hospital. Based on the Prague C & M Criteria, they originally classified cases of Barrett’s epithelium into two types based on its shape, namely, flame-like and lotus-like Barrett’s epithelium, and into two groups based on its length, its C extent < 2 cm, and ≥ 2 cm.

They found that Barrett’s epithelium was diagnosed in 374 cases (43%). Most of these were diagnosed as short-segment Barrett’s epithelium. The prevalence of erosive esophagitis was significantly higher in subjects with flame-like than lotus-like Barrett’s epithelium, and in those with a C extent of ≥ 2 cm than < 2 cm.

This study may represent a future strategy for intervention in the prevention of esophageal adenocarcinoma.

###

Reference
Akiyama T, Inamori M, Iida H, Endo H, Hosono K, Sakamoto Y, Fujita K, Yoneda M, Takahashi H, Koide T, Tokoro C, Goto A, Abe Y, Shimamura T, Kobayashi N, Kubota K, Saito S, Nakajima A. Shape of Barrett’s epithelium is associated with prevalence of erosive esophagitis. World J Gastroenterol 2010; 16(4): 484-489

Correspondence to
Masahiko Inamori, MD, PhD, Gastroenterology Division, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.

Telephone
+81-45-7872640 Fax: +81-45-7843546

About World Journal of Gastroenterology
World Journal of Gastroenterology (WJG), a leading international journal in gastroenterology and hepatology, has established a reputation for publishing first class research on esophageal cancer, gastric cancer, liver cancer, viral hepatitis, colorectal cancer, and H. pylori infection and provides a forum for both clinicians and scientists. WJG has been indexed and abstracted in Current Contents/Clinical Medicine, Science Citation Index Expanded (also known as SciSearch) and Journal Citation Reports/Science Edition, Index Medicus, MEDLINE and PubMed, Chemical Abstracts, EMBASE/Excerpta Medica, Abstracts Journals, Nature Clinical Practice Gastroenterology and Hepatology, CAB Abstracts and Global Health. ISI JCR 2008 IF: 2.081. WJG is a weekly journal published by WJG Press. The publication dates are the 7th, 14th, 21st, and 28th day of every month. WJG is supported by The National Natural Science Foundation of China, No. 30224801 and No. 30424812, and was founded with the name of China National Journal of New Gastroenterology on October 1, 1995, and renamed WJG on January 25, 1998.

Contact: Ye-Ru Wang

86-105-908-0039
World Journal of Gastroenterology

RELATED STORIES:
FDA says ulcer drugs may raise diarrhea risk   Rotavirus vaccine not linked to bowel problems   Rotavirus Vaccine Not Associated with Increased Risk of Intestinal Disorder in US Infants   Ulcer-causing bug tied to higher diabetes risk   Five Reasons Not to Put Off a Colonoscopy   New therapeutic target to combat liver cancer discovered   GERD in Infants and Children   An easier way to remove gallstones   Radical Liver Surgery, West Coast First   Inflammatory Bowel Disease Emerges as a Global Disease   Feeling Stressed? Why You May Feel It in Your Gut   Rare genetic disorder provides clues to development of the pancreas   Genes modify the risk of liver disease among alcoholics   Fatty livers are in overdrive   Use of opioid painkillers for abdominal pain has more than doubled

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]